Adamis Pharmaceuticals announces proposed public offering of common stock
Adamis Pharmaceuticals announced that it intends to offer to sell shares of its common stock in an underwritten public offering. The company expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered. April 20, 2017